![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MT1G |
Gene summary for MT1G |
![]() |
Gene information | Species | Human | Gene symbol | MT1G | Gene ID | 4495 |
Gene name | metallothionein 1G | |
Gene Alias | MT1 | |
Cytomap | 16q13 | |
Gene Type | protein-coding | GO ID | GO:0001775 | UniProtAcc | P13640 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4495 | MT1G | GSM4909282 | Human | Breast | IDC | 2.37e-14 | 4.67e-01 | -0.0288 |
4495 | MT1G | GSM4909286 | Human | Breast | IDC | 2.00e-78 | 1.12e+00 | 0.1081 |
4495 | MT1G | GSM4909289 | Human | Breast | IDC | 6.90e-10 | 8.73e-01 | 0.1064 |
4495 | MT1G | GSM4909293 | Human | Breast | IDC | 2.27e-18 | 5.04e-01 | 0.1581 |
4495 | MT1G | GSM4909294 | Human | Breast | IDC | 3.78e-06 | -1.69e-01 | 0.2022 |
4495 | MT1G | GSM4909301 | Human | Breast | IDC | 7.33e-04 | -1.78e-01 | 0.1577 |
4495 | MT1G | GSM4909304 | Human | Breast | IDC | 2.45e-34 | 7.87e-01 | 0.1636 |
4495 | MT1G | GSM4909306 | Human | Breast | IDC | 1.54e-24 | 6.17e-01 | 0.1564 |
4495 | MT1G | GSM4909308 | Human | Breast | IDC | 3.00e-04 | -1.90e-01 | 0.158 |
4495 | MT1G | GSM4909309 | Human | Breast | IDC | 4.91e-06 | 3.67e-01 | 0.0483 |
4495 | MT1G | GSM4909311 | Human | Breast | IDC | 5.56e-11 | 2.66e-01 | 0.1534 |
4495 | MT1G | GSM4909315 | Human | Breast | IDC | 1.72e-05 | -1.84e-01 | 0.21 |
4495 | MT1G | GSM4909319 | Human | Breast | IDC | 8.07e-06 | -1.75e-01 | 0.1563 |
4495 | MT1G | GSM4909321 | Human | Breast | IDC | 3.78e-06 | -1.90e-01 | 0.1559 |
4495 | MT1G | NCCBC5 | Human | Breast | DCIS | 2.20e-05 | 2.77e-01 | 0.2046 |
4495 | MT1G | P1 | Human | Breast | IDC | 1.41e-03 | -1.90e-01 | 0.1527 |
4495 | MT1G | DCIS2 | Human | Breast | DCIS | 4.22e-09 | -7.81e-02 | 0.0085 |
4495 | MT1G | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.19e-03 | 2.51e-01 | 0.0155 |
4495 | MT1G | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.90e-34 | 1.89e+00 | -0.1808 |
4495 | MT1G | HTA11_2951_2000001011 | Human | Colorectum | AD | 3.54e-06 | 7.94e-01 | 0.0216 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005507631 | Stomach | SIM | transition metal ion homeostasis | 12/708 | 138/18723 | 6.18e-03 | 4.90e-02 | 12 |
GO:000963627 | Thyroid | HT | response to toxic substance | 50/1272 | 262/18723 | 2.25e-11 | 3.75e-09 | 50 |
GO:009875420 | Thyroid | HT | detoxification | 36/1272 | 152/18723 | 2.63e-11 | 4.07e-09 | 36 |
GO:004668625 | Thyroid | HT | response to cadmium ion | 17/1272 | 68/18723 | 2.05e-06 | 7.51e-05 | 17 |
GO:001003830 | Thyroid | HT | response to metal ion | 50/1272 | 373/18723 | 3.12e-06 | 1.08e-04 | 50 |
GO:19031319 | Thyroid | HT | mononuclear cell differentiation | 54/1272 | 426/18723 | 6.88e-06 | 2.00e-04 | 54 |
GO:007124119 | Thyroid | HT | cellular response to inorganic substance | 34/1272 | 226/18723 | 1.03e-05 | 2.79e-04 | 34 |
GO:004668818 | Thyroid | HT | response to copper ion | 12/1272 | 42/18723 | 1.50e-05 | 3.76e-04 | 12 |
GO:007127617 | Thyroid | HT | cellular response to cadmium ion | 11/1272 | 40/18723 | 5.03e-05 | 9.95e-04 | 11 |
GO:009750115 | Thyroid | HT | stress response to metal ion | 7/1272 | 19/18723 | 1.60e-04 | 2.42e-03 | 7 |
GO:003009930 | Thyroid | HT | myeloid cell differentiation | 45/1272 | 381/18723 | 2.07e-04 | 3.00e-03 | 45 |
GO:001027310 | Thyroid | HT | detoxification of copper ion | 6/1272 | 15/18723 | 2.85e-04 | 3.86e-03 | 6 |
GO:199016910 | Thyroid | HT | stress response to copper ion | 6/1272 | 15/18723 | 2.85e-04 | 3.86e-03 | 6 |
GO:007124820 | Thyroid | HT | cellular response to metal ion | 27/1272 | 197/18723 | 3.85e-04 | 4.85e-03 | 27 |
GO:00712808 | Thyroid | HT | cellular response to copper ion | 8/1272 | 28/18723 | 4.05e-04 | 5.02e-03 | 8 |
GO:00459269 | Thyroid | HT | negative regulation of growth | 31/1272 | 249/18723 | 8.02e-04 | 8.75e-03 | 31 |
GO:00616878 | Thyroid | HT | detoxification of inorganic compound | 6/1272 | 18/18723 | 8.86e-04 | 9.30e-03 | 6 |
GO:004691616 | Thyroid | HT | cellular transition metal ion homeostasis | 16/1272 | 115/18723 | 4.78e-03 | 3.29e-02 | 16 |
GO:00022745 | Thyroid | HT | myeloid leukocyte activation | 26/1272 | 223/18723 | 4.98e-03 | 3.36e-02 | 26 |
GO:005507619 | Thyroid | HT | transition metal ion homeostasis | 18/1272 | 138/18723 | 5.75e-03 | 3.72e-02 | 18 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0497812 | Breast | IDC | Mineral absorption | 13/867 | 60/8465 | 6.73e-03 | 3.42e-02 | 2.56e-02 | 13 |
hsa0497813 | Breast | IDC | Mineral absorption | 13/867 | 60/8465 | 6.73e-03 | 3.42e-02 | 2.56e-02 | 13 |
hsa0497821 | Breast | DCIS | Mineral absorption | 13/846 | 60/8465 | 5.48e-03 | 2.81e-02 | 2.07e-02 | 13 |
hsa0497831 | Breast | DCIS | Mineral absorption | 13/846 | 60/8465 | 5.48e-03 | 2.81e-02 | 2.07e-02 | 13 |
hsa0497814 | Prostate | BPH | Mineral absorption | 20/1718 | 60/8465 | 1.22e-02 | 3.61e-02 | 2.23e-02 | 20 |
hsa0497815 | Prostate | BPH | Mineral absorption | 20/1718 | 60/8465 | 1.22e-02 | 3.61e-02 | 2.23e-02 | 20 |
hsa04978 | Stomach | GC | Mineral absorption | 15/708 | 60/8465 | 8.88e-05 | 9.80e-04 | 6.90e-04 | 15 |
hsa049781 | Stomach | GC | Mineral absorption | 15/708 | 60/8465 | 8.88e-05 | 9.80e-04 | 6.90e-04 | 15 |
hsa049782 | Stomach | CAG with IM | Mineral absorption | 12/640 | 60/8465 | 1.52e-03 | 1.01e-02 | 7.10e-03 | 12 |
hsa049783 | Stomach | CAG with IM | Mineral absorption | 12/640 | 60/8465 | 1.52e-03 | 1.01e-02 | 7.10e-03 | 12 |
hsa049784 | Stomach | CSG | Mineral absorption | 11/633 | 60/8465 | 4.40e-03 | 2.53e-02 | 1.82e-02 | 11 |
hsa049785 | Stomach | CSG | Mineral absorption | 11/633 | 60/8465 | 4.40e-03 | 2.53e-02 | 1.82e-02 | 11 |
hsa049786 | Stomach | CAG | Mineral absorption | 8/368 | 60/8465 | 4.18e-03 | 2.94e-02 | 2.36e-02 | 8 |
hsa049787 | Stomach | CAG | Mineral absorption | 8/368 | 60/8465 | 4.18e-03 | 2.94e-02 | 2.36e-02 | 8 |
hsa049788 | Stomach | SIM | Mineral absorption | 11/465 | 60/8465 | 3.61e-04 | 3.41e-03 | 2.74e-03 | 11 |
hsa049789 | Stomach | SIM | Mineral absorption | 11/465 | 60/8465 | 3.61e-04 | 3.41e-03 | 2.74e-03 | 11 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MT1G | SNV | Missense_Mutation | c.185C>T | p.Ala62Val | p.A62V | P13640 | protein_coding | deleterious_low_confidence(0.02) | benign(0.399) | TCGA-AA-A01P-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
MT1G | SNV | Missense_Mutation | novel | c.14N>A | p.Cys5Tyr | p.C5Y | P13640 | protein_coding | deleterious_low_confidence(0.01) | probably_damaging(0.99) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
MT1G | SNV | Missense_Mutation | novel | c.137N>T | p.Ala46Val | p.A46V | P13640 | protein_coding | deleterious(0.04) | possibly_damaging(0.463) | TCGA-AX-A0J1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MT1G | SNV | Missense_Mutation | c.49N>T | p.Ala17Ser | p.A17S | P13640 | protein_coding | tolerated_low_confidence(0.23) | benign(0.111) | TCGA-73-4670-01 | Lung | lung adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | SD | |
MT1G | SNV | Missense_Mutation | rs546669333 | c.164C>T | p.Ser55Leu | p.S55L | P13640 | protein_coding | tolerated(0.18) | benign(0.001) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR |
MT1G | SNV | Missense_Mutation | rs370776559 | c.49N>A | p.Ala17Thr | p.A17T | P13640 | protein_coding | tolerated_low_confidence(0.2) | benign(0.003) | TCGA-VQ-A8P2-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unspecific | Complete Response |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
4495 | MT1G | NA | BSO | 8966720 |
Page: 1 |